These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 17917520)
1. Where are we going? Beyond JNC 7. Giles TD; Oparil S; Pickering TG Prev Cardiol; 2007; 10(4):222-7. PubMed ID: 17917520 [TBL] [Abstract][Full Text] [Related]
2. Roundtable discussion: blood pressure goal attainment: meeting the challenge of the JNC 7's blood pressure goals and the role of renin-angiotensin-aldosterone system blockade. Weber M; Basile J; Izzo J; Oparil S J Clin Hypertens (Greenwich); 2004 Dec; 6(12):699-705. PubMed ID: 15599118 [TBL] [Abstract][Full Text] [Related]
3. Conflicting and confusing data from the hypertension treatment trials: whom and what should you believe? Moser M; Giles T; Oparil S J Clin Hypertens (Greenwich); 2005 Jul; 7(7):403-8. PubMed ID: 16015050 [TBL] [Abstract][Full Text] [Related]
4. Roundtable discussion: hypertension in children and adolescents. Moser M; Giles TD; Falkner B; Schwartz AB; Townsend RR J Clin Hypertens (Greenwich); 2005 Jan; 7(1):24-30. PubMed ID: 15655383 [TBL] [Abstract][Full Text] [Related]
5. The cardiometabolic syndrome and calcium channel blocker combination drugs. Sowers JR; Bakris GL; Black HR; Giles TD J Cardiometab Syndr; 2007; 2(3):207-12. PubMed ID: 17786085 [TBL] [Abstract][Full Text] [Related]
6. The ALLHAT study revisited: do newer data from this trial and others indicate changes in treatment guidelines? Moser M; Oparil S; Cushman W; Papademetriou V J Clin Hypertens (Greenwich); 2007 May; 9(5):372-80. PubMed ID: 17485973 [TBL] [Abstract][Full Text] [Related]
8. Roundtable discussion: the role of Beta blockers in the management of hypertension. Moser M; Pickering TG; Cushman WC J Clin Hypertens (Greenwich); 2005 May; 7(5):295-9. PubMed ID: 15886532 [TBL] [Abstract][Full Text] [Related]
9. Interview with Suzanne Oparil, MD. Interview by Marvin Moser, MD. Oparil S J Clin Hypertens (Greenwich); 2004 Sep; 6(9):509-12. PubMed ID: 15365278 [TBL] [Abstract][Full Text] [Related]
10. Secondary hypertension--whom and how do you study? What type of therapy is appropriate? Moser M; Victor R; Handler J J Clin Hypertens (Greenwich); 2005 Apr; 7(4):224-30. PubMed ID: 15860962 [TBL] [Abstract][Full Text] [Related]
11. Blood pressure control in the patient with difficult-to-control hypertension: which agent for which patient? Bakris GL; Sowers JR; Ferdinand KC Prev Cardiol; 2008; 11(1):42-9. PubMed ID: 18174791 [TBL] [Abstract][Full Text] [Related]
12. Control of blood pressure: does it matter which agent you use? Moser M; Cushman WC; Kaplan NM J Clin Hypertens (Greenwich); 2007 Dec; 9(12):964-73. PubMed ID: 18046103 [TBL] [Abstract][Full Text] [Related]
13. Review of new hypertension guidelines. Zhang PY Eur Rev Med Pharmacol Sci; 2015; 19(2):312-5. PubMed ID: 25683948 [TBL] [Abstract][Full Text] [Related]
14. ACE inhibitors: over two decades of use. Sica DA; Giles TD; Black HR; Campese VM J Clin Hypertens (Greenwich); 2005 Sep; 7(9):531-7. PubMed ID: 16227772 [TBL] [Abstract][Full Text] [Related]
20. Controversies in the diagnosis and treatment of hypertension: a personal review of JNC V. Weber MA Am J Cardiol; 1993 Dec; 72(20):3H-9H. PubMed ID: 8285180 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]